Nevralgio (Paracetamol, Acetylsalicylic Acid, Caffeine)

Paracetamol, Acetylsalicylic Acid and Caffeine, the active ingredients in Nevralgio, form an analgesic and antipyretic combination presented as an oral tablet for oral use. The product is intended to relieve mild to moderate pain and reduce fever in adults and adolescents.

GNH USA supplies Nevralgio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable global distribution.

Nevralgio is used to manage pain and fever by acting on prostaglandin pathways.

- Headache: provides rapid relief of tension‑type and mild migraine pain. - Fever: reduces elevated body temperature in febrile conditions. - Mild to moderate pain: alleviates dental, musculoskeletal, and postoperative discomfort.

Like all medicines, Nevralgio may cause unwanted reactions.

Common Side Effects: - Nausea: mild stomach upset. - Gastric irritation: discomfort or heartburn. - Insomnia: difficulty sleeping due to caffeine. - Increased heart rate: mild palpitations.

Serious or Rare Side Effects: - Gastrointestinal bleeding: black stools or vomiting blood. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Liver toxicity: jaundice or elevated liver enzymes with excessive use.

Before using Nevralgio, consider the following safety measures. - Assess liver function: avoid use in patients with severe hepatic impairment. - Evaluate bleeding risk: caution in individuals with ulcers, anticoagulant therapy, or clotting disorders. - Monitor caffeine intake: limit additional stimulants to reduce insomnia or tachycardia. - Avoid use in children under 12 years: safety not established for this age group. - Pregnancy and breastfeeding: consult a healthcare professional as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Nevralgio can interact with other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin‑containing products: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - Diuretics: caffeine may reduce diuretic effectiveness. - Antihypertensives: caffeine can counteract blood‑pressure‑lowering effects. - Methotrexate: aspirin may decrease renal clearance, raising toxicity risk.